WEE1 and head and neck squamous cell carcinoma: Moreover, Wee1 inhibitor adavosertib shows the potential for overcoming cisplatin resistance, and the combination of adavosertib and cisplatin inhibits tumor proliferation and survival with synergy in cisplatin-resistant HNSCC by inducing DNA damage [76].